Asahi Intecc Co Ltd (JP:7747)
:7747
Want to see JP:7747 full AI Analyst Report?
7747 Stock Chart & Stats
¥3496.00
¥15.50(0.61%)
At close: 4:00 PM EST
¥3496.00
¥15.50(0.61%)
Day’s Range― - ―
52-Week Range¥2,127.00 - ¥3,698.00
Previous CloseN/A
Volume766.90K
Average Volume (3M)951.34K
Market Cap
¥875.04B
Enterprise Value¥860.14B
Total Cash (Recent Filing)¥54.20B
Total Debt (Recent Filing)¥11.52B
Price to Earnings (P/E)24.3
Beta0.82
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.82%
Share Statistics
EPS (TTM)N/A
Shares Outstanding265,332,300
10 Day Avg. Volume923,580
30 Day Avg. Volume951,336
Financial Highlights & Ratios
PEG Ratio-2.51
Price to Book (P/B)4.12
Price to Sales (P/S)5.16
P/FCF Ratio19.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,200.00Price Target Upside20.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent double-digit revenue growth (17.7% most recent year) indicates expanding clinical adoption and market share in interventional cardiology. Because core products are procedure-driven consumables, sustained revenue growth supports reinvestment, scale efficiencies, and durable demand.
High Margins & Cash ConversionVery high gross margins and strong cash conversion (operating cash flow to net income 1.46, FCF/net income 0.80) show pricing power and operational efficiency. Reliable cash generation funds R&D, distribution expansion and provides a buffer through procedure cycles, enhancing long-term resilience.
Strong Balance SheetExtremely low leverage (debt/equity 0.07) and a robust equity base give the company financial flexibility for targeted M&A, product development, and international expansion. Low refinancing risk and balance-sheet strength help sustain operations through industry cycles.
Bears Say
Margin PressureReported declines in EBIT/EBITDA margins and a falling ROE (now 8.46%) point to margin compression from cost inflation, pricing pressure, or mix shifts. Continued margin erosion would limit free cash flow expansion and constrain funding for R&D, commercialization, and shareholder returns.
Negative EPS GrowthNegative EPS growth despite revenue gains suggests rising operating costs, adverse mix, or investment-related dilution. If per-share profitability does not recover, capital available for reinvestment, dividends, or strategic initiatives could be constrained over the medium term.
Procedure-Volume DependenceRevenue concentration in single-use interventional devices ties performance to procedure volumes, reimbursement trends, and physician/hospital formulary decisions. This exposes growth to structural shifts in procedure rates and competitive adoption barriers, requiring sustained product differentiation and execution.
Asahi Intecc Co News
7747 FAQ
What was Asahi Intecc Co Ltd’s price range in the past 12 months?
Asahi Intecc Co Ltd lowest stock price was ¥2127.00 and its highest was ¥3698.00 in the past 12 months.
What is Asahi Intecc Co Ltd’s market cap?
Asahi Intecc Co Ltd’s market cap is ¥875.04B.
When is Asahi Intecc Co Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Asahi Intecc Co Ltd’s earnings last quarter?
Currently, no data Available
Is Asahi Intecc Co Ltd overvalued?
According to Wall Street analysts Asahi Intecc Co Ltd’s price is currently Undervalued.
Does Asahi Intecc Co Ltd pay dividends?
Asahi Intecc Co Ltd pays a Annually dividend of ¥24.23 which represents an annual dividend yield of 0.82%. See more information on Asahi Intecc Co Ltd dividends here
What is Asahi Intecc Co Ltd’s EPS estimate?
Asahi Intecc Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Asahi Intecc Co Ltd have?
Asahi Intecc Co Ltd has 265,332,300 shares outstanding.
What happened to Asahi Intecc Co Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Asahi Intecc Co Ltd?
Currently, no hedge funds are holding shares in JP:7747
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asahi Intecc Co Ltd
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, the Middle East, China, and internationally. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. It also offers OEM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products, as well as develops, manufactures, and sells ultra-fine stainless steel wire ropes, terminal processed products, etc. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Aichi, Japan.
7747 Stock 12 Month Forecast
Average Price Target
¥4,200.00
▲(20.14% Upside)
Technical Analysis
Options Prices
Currently, No data available
---